Tabuk Pharmaceuticals Partners with Biocon to Bring GLP-1 Diabetes and Weight Management Therapies to the Middle East Riyadh – Tabuk Pharmaceutical Manufacturing Company, a fully owned subsidiary of Astra Industrial Group and one of the leading pharmaceutical companies in the Middle…
Formosa Pharmaceuticals Announces Exclusive Licensing Agreement with Tabuk Pharmaceuticals, for the Commercialization of Clobetasol Propionate Ophthalmic Suspension, a Novel Medicine for the Treatment of Inflammation and Pain Following Ocular Surgery
Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced today an exclusive license agreementwith Formosa Pharmaceuticals for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine…
Tabuk Pharmaceuticals and Globalpharma Sign an Agreement to Locally manufacture Key Pharmaceutical products in UAE.
Globalpharma and Tabuk Pharmaceuticals, leaders in the pharmaceutical industry in the Middle East and North Africa, announced the signing of a cooperation agreement aimed at enabling local manufacturing of several products by Tabuk Pharmaceuticals in the United Arab Emirates. The signing…
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
Agreement also includes distribution of Moderna’s updated variant booster candidates CAMBRIDGE, Mass. & ZUG, Switzerland–(BUSINESS WIRE)—June 11, 2021– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned…